Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation

BACKGROUND: Safety regarding switching from vitamin K antagonist (VKA) to dabigatran therapy in post-ablation patients has never been investigated and safety data for this is urgently needed. The objective of this study was to examine if switch from VKA to dabigatran increased the risk of stroke, bl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Pallisgaard, Jannik Langtved, Gislason, Gunnar Hilmar, Torp-Pedersen, Christian, Lee, Christina Ji-Young, Sindet-Pedersen, Caroline, Staerk, Laila, Olesen, Jonas Bjerring, Lindhardt, Tommi Bo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2016
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4999147/
https://ncbi.nlm.nih.gov/pubmed/27560967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0161768
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak